Schering-Plough profit eclipses expectations
641779
Schering-Plough Corp.  on  Monday reported quarterly earnings far higher than Wall Street  expected, fueled by growing demand for its drugs against  cholesterol, arthritis, allergies and hepatitis C.
457209
Akzo Nobel  said on Monday it was selling its drugs unit Organon BioSciences to Schering-Plough  for 11 billion euros ($14.4 billion), in a last-minute reversal of plans to float it on the stock market.
434553
South Korea's Hynix Semiconductor Inc.  said fourth-quarter profit rose 35 percent to a record high,  beating estimates, on strong sales of computer memory chips,  but forecast steep falls in chip prices.
493014
European shares edged higher at Monday&#39;s opening led by Germany&#39;s Bayer on news of an alliance with US healthcare giant Schering-Plough.
401858
Swedish aviation and defence group Saab said Friday its second-quarter profit soared by 45 percent, exceeding analysts&#39; expectations, owing to strong sales despite a plunge in orders.
46436
Third-quarter profit, helped by sales of jet fighters and electronic warfare systems, beat Wall Street expectations, but the companyâs forecast for next year was slightly below analystsâ estimates.
302408
Swiss drugmaker Roche beat forecasts  with a 37 percent rise in first-half net income to 4.543  billion Swiss francs ($3.62 billion), boosted by bumper growth  in its cancer drugs.
746919
Drug maker Schering-Plough Corp   on Tuesday reported a fourth-quarter loss as special  charges from its acquisition of Organon Biosciences late last  year offset sharply higher sales.
541389
BOSTON, Aug. 29 -- Schering-Plough Corp. on Tuesday agreed to pay $435 million and plead guilty to conspiracy to settle a federal investigation into marketing of its drugs for unapproved uses and overcharging Medicaid for certain drugs.
692853
Schering-Plough Corp  said on Thursday that it expects to report higher sales of its cholesterol drugs Vytorin and Zetia in the fourth quarter of 2007 and in 2008 even though they face growing competition.
692786
NEW YORK - Pfizer Inc. said Wednesday that third quarter earnings, excluding charges, beat Wall Street expectations by a penny, on strong sales of Lipitor and Celebrex medicines.
43644
Schering-Plough Corp.  said on Monday that second-quarter earnings rose sharply, fueled by growing demand for its Zetia and Vytorin cholesterol drugs and treatments for arthritis and allergies.
323016
German drugs and chemicals group Merck has reported quarterly earnings that have easily beaten forecasts thanks to strong sales of cancer drug Erbitux and a one-off payment for an alcoholism drug.
510118
Sanofi-Aventis  posted higher-than-expected fourth-quarter current operating profit, despite healthcare savings in Europe as well as generic rivalry, and the drugmaker predicted more growth for 2007.
427900
BOSTON  Â Biogen Idec said on Wednesday its fourth-quarter profit rose 84 percent, topping expectations, driven by increased sales of its multiple sclerosis drugs Avonex and Tysabri.
10796
Net profit in the fourth quarter rose to 753 million euros ($1.09 billion), helped by sales of the blood-thinner Plavix in the United States and cost-cutting measures, the company said.
710615
Schering ups '04 earnings, Yasmin sales forecasts (4:41 AM ET) LONDON (CBS.MW) -- German drugmaker Schering( SHR )(DE:717200DE:717200)said it was upping its 2004 earnings forecast on a more favorable tax rate ...